Description

Modified GRF 1 29

Modified GRF 129 (CJC-1295 no DAC) is a research-grade, synthetic peptide derived from Growth Hormone Releasing Hormone (GHRH). Often called ModGRF(1-29), it is designed with four amino acid substitutions (D-Ala, Gln, Ala, Leu) at positions 2, 8, 15, and 27, creating a highly stable peptide resistant to degradation and oxidation. These modifications enhance binding to GHRH receptors and improve bioactivity, while maintaining a short-acting half-life similar to natural pulses of GH.

This peptide is not the same as CJC-1295 with DAC. Unlike the long-acting CJC-1295, Modified GRF 1 29 has a half-life of approximately 30 minutes, mimicking natural GH pulses. This short half-life is preferred in some research studies, as it produces a more physiologically relevant GH response.

Key Research Benefits:

• Short-acting GHRH analog for precise GH stimulation

• Supports studies on cellular repair, growth, and tissue regeneration

• Lab-tested and validated for high purity and stability

• Ideal for experimental research in controlled lab environments

Chemical & Structural Information:

• Peptide type: Modified GRF 1 29

• Sequence: 29 amino acids with tetrasubstitution

• Form: Lyophilized powder

• Purity: ≥99% HPLC verified

• Storage: -20°C recommended for long-term stability

• 

Strictly for Research Use Only (RUO)
Modified GRF 1-29 is intended solely for scientific research. It is not for human consumption or clinical use. Researchers worldwide utilize this peptide to study GH mechanisms, cellular regeneration, and experimental therapeutic potentials in controlled laboratory settings.

EssentiaPeptides guarantees consistent quality, batch-to-batch purity, and accurate labeling. Each peptide is supplied with a Certificate of Analysis (COA) to ensure reproducibility and confidence in experimental results.